Median Diagnostics Inc. (XKON:233250)
South Korea · Delayed Price · Currency is KRW 4,900.00
-100.00 (-2.00%)
At close: Jul 31, 2026
Median Diagnostics Market Cap
Median Diagnostics has a market cap or net worth of 8.56 billion as of July 31, 2026. Its market cap has decreased by -63.70% in one year.
Market Cap
8.56B
Enterprise Value
n/a
Revenue
7.86B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,900.00
ChartMarket Cap Chart
Since June 26, 2017, Median Diagnostics's market cap has decreased from 22.09B to 8.56B, a decrease of -61.26%. That is a compound annual growth rate of -9.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 8.56B | -57.32% |
| Dec 30, 2025 | 20.05B | -20.83% |
| Dec 30, 2024 | 25.32B | -9.32% |
| Dec 28, 2023 | 27.93B | -44.77% |
| Dec 29, 2022 | 50.56B | -27.35% |
| Dec 30, 2021 | 69.60B | -3.28% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 26, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 3billion | 163.57B |
| GENINUS | 79.38B |
| Cytogen | 65.17B |
| Protia | 64.01B |
| GC Medical Science | 54.14B |
| Inventera | 54.12B |
| HLB Panagene | 46.98B |
| Seoulin Bioscience | 37.16B |